Trademarkia Logo

Canada

C$
Trademark Search in Canada
AOP ORPHAN

View On IC.GC.CA

AOP ORPHAN
REGISTERED

on 17 Jun 2019

Last Applicant/ Owned by

AOP HEALTH INTERNATIONAL MANAGEMENT AG

Industriering 209491 Ruggell,

LI

Serial Number

1775857 filed on 6th Apr 2016

Registration Number

TMA1026686 registered on 17th Jun 2019

Registration expiry Date

17th Jun 2029

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

AOP ORPHAN

Trademark usage description

pharmaceutical preparations in the field of haematology, namely, for the treatment of blood disorders and myeloproliferative neoplasms, oncology, pulm Read More

Classification Information

Class [005]
Pharmaceutical preparations in the field of haematology, namely, for the treatment of blood disorders and myeloproliferative neoplasms, oncology, pulmonology, cardiology, neurology, namely, Alzheimer's disease, dementia, Huntington's disease, spinal injury, brain injury, narcolepsy, epilepsy and agitation, psychiatry, namely, schizophrenia and bipolar disorders, metabolic diseases, namely, diabetes, hypoglycemia, gout, muscular dystrophy, osteoarthritis and anemia and genetic disorders, namely, cystic fibrosis, Down syndrome, haemophilia, phenylketonuria, sickle-cell disease, fragile X-syndrome, fragile X associated ataxia and tremor and spinal muscular atrophy; orphan and niche generic pharmaceutical preparations in the field of haematology, namely, for the treatment of blood disorders and myeloproliferative neoplasms, oncology, pulmonology, cardiology, neurology, namely, Alzheimer's disease, dementia, Huntington's disease, spinal injury, brain injury, narcolepsy, epilepsy and agitation, psychiatry, namely schizophrenia and bipolar disorders, metabolic diseases, namely, diabetes, hypoglycemia, gout, muscular dystrophy, osteoarthritis and anemia, and genetic disorders, namely, cystic fibrosis, Down syndrome, haemophilia, phenylketonuria, sickle-cell disease, fragile X-syndrome, fragile X associated ataxia and tremor, and spinal muscular atrophy.

Classification kind code

10

Class [035]
Providing a website featuring information promoting public awareness of pharmaceutical preparations; business marketing consulting services in the field of medication; advisory and assistance services in the field of medication, namely business management advisory services in the field of medication.

Classification kind code

10

Class [039]
Distribution of medication.

Classification kind code

10

Class [042]
Medical and pharmaceutical research and development in the field of haematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; scientific research and development services in the field of haematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; industrial research, namely, medical and pharmaceutical research, and research of vaccines and medicines in the field of haematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; professional consultancy services in the fields of medical and pharmaceutical research and development; contract research services, namely, medical and pharmaceutical research, and research of vaccines and medicines in the field of haematology, oncology, cardiology, neurology, psychiatry, metabolic diseases and genetic disorders; computer programming.

Classification kind code

10

Mark Details

Serial Number

1775857

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 23rd May 2018		Advertised
Submitted for opposition 26
on 3rd May 2018		Approved
Submitted for opposition 27
on 13th Mar 2018		Approval Notice Sent
Submitted for opposition 15
on 20th Nov 2017		Correspondence Created
Submitted for opposition 15
on 11th Jul 2017		Correspondence Created
Submitted for opposition 22
on 16th Sept 2016		Search Recorded
Submitted for opposition 20
on 16th Sept 2016		Examiner's First Report
Submitted for opposition 31
on 8th Apr 2016		Formalized
Submitted for opposition 30
on 6th Apr 2016		Filed
Submitted for opposition 1
on 6th Apr 2016		Created